“I am elated to hear of the approval of my O1A visa. I owe it to your hard work and dedication to ensure that my case was prepared perfectly. I want to thank every person on the team that helped make this happen, I really appreciate it… It has always been a pleasure, and your firm is the Gold Standard of how all firms should conduct and interact with their clients.”

Case Summary:

A pulmonary and critical care medicine fellow with an M.B.B.S degree approached North America Immigration Law Group to obtain an O1-A (Individuals with Extraordinary Ability or Achievement) visa. He needed our support to file an I-129 petition on his behalf, exhibiting him as an individual with extraordinary ability to advance his groundbreaking work on the serious adverse events of approved drugs since he has acquired a rare skill set in internal medicine research that distinguishes him from the rest of his peers. This has enabled him to conduct truly innovative and impactful internal medicine studies that are much needed in the United States and abroad.

Therefore, we aimed to prove the importance of our client’s research to the USCIS. We evaluated his research focusing on drug safety profiles. After a thorough review, we figured out that our client’s research directly addresses critical issues in understanding the effects of federally approved drugs, and his strong background in pulmonary medicine and critical care medicine has allowed his research to be particularly original, with applications such as improving public healthcare. Also, his many years of experience as well as his leadership and expertise in the field, thus have established eligibility for his petition to be approved.

Besides, we noted his citation and publication record, including 23 peer-reviewed journal articles, 8 Letters to the Editor, and 1 published clinical picture that had amassed 102 citations from other superior researchers in the field. His work has been published in journals of elite international platforms for the review and exchange of research. Thus, his publication in them is strong evidence of the value and significance of his work to the international research community. Moreover, at the time of filing, he had also conducted at least 5 peer reviews for 3 highly acclaimed journals and completed 86 abstract reviews for other established journals. He is also a member of the editorial boards of remarkable journals whereas only top-level experts in their field are invited to perform this important review work, so this frequent review activity further demonstrates his respected position in the field.

Towards the finalization of his petition, we added five recommendation letters obtained from other experts in the field along with the aforementioned details. According to one of the independent advisors:

“In particular, [client] conducted a detailed study of pharmaceutical-induced adverse events in order to provide more quality reports and more compelling evidence of serious adverse outcomes…He also used probability scoring and previous literature to determine whether specific events were caused as a side effect of the drug in question. This information allows doctors and drug manufacturers to both effectively treat patients and maintain patient safety worldwide.”

Gladly, we impressed USCIS by affirming the quality of our client’s research, which is truly exceptional, evidenced by his publication and citation records and the important applications that his research boasts. With such a unique research background, he has propelled himself to the forefront of the field. Considering his well-established record as a leader in the field of internal medicine, we are certain that he will continue to contribute high-quality work for many years to come. Therefore, USCIS spent only 8 days adjudicating our client’s case and granted him the O1-A approval, thanks to premium processing and our commitment towards securing the O1-A approval for him. We congratulate him on this breakthrough and wish him well in his future projects.